Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Apr-24 4:27 PM View:  | Muzzey Dale Chief Scientific Officer | Myriad Genetics Inc. (MYGN) | 14-Apr-24 | Payment of Exercise | 940 | $19.55 | $18,377.00 | (< 1%) 111.05K to 110.11K | |
| 15-Apr-24 4:25 PM View: | Verratti Mark Chief Commercial Officer | Myriad Genetics Inc. (MYGN) | 14-Apr-24 | Payment of Exercise | 1,076 | $19.55 | $21,035.80 | (< 1%) 299.79K to 298.71K | |
| 08-Apr-24 4:49 PM View: | Munk Natalie Chief Accounting Officer | Myriad Genetics Inc. (MYGN) | 06-Apr-24 | Payment of Exercise | 581 | $20.26 | $11,771.10 | (1%) 45.02K to 44.44K | |
| 27-Mar-24 4:17 PM View: | Munk Natalie Chief Accounting Officer | Myriad Genetics Inc. (MYGN) | 25-Mar-24 | Payment of Exercise | 363 | $21.98 | $7,978.74 | (< 1%) 45.38K to 45.02K | (17%) |
| 25-Mar-24 4:31 PM View: | Haas Kevin Richard Chief Technology Officer | Myriad Genetics Inc. (MYGN) | 24-Mar-24 | Payment of Exercise | 2,890 | $22.24 | $64,273.60 | (2%) 134.99K to 132.1K | (16%) |
| 25-Mar-24 4:31 PM View: | Muzzey Dale Chief Scientific Officer | Myriad Genetics Inc. (MYGN) | 24-Mar-24 | Payment of Exercise | 943 | $22.24 | $20,972.30 | (< 1%) 112.0K to 111.05K | (16%) |
| 25-Mar-24 4:31 PM View: | Verratti Mark Chief Commercial Officer | Myriad Genetics Inc. (MYGN) | 24-Mar-24 | Payment of Exercise | 3,245 | $22.24 | $72,168.80 | (1%) 303.04K to 299.79K | (16%) |
| 25-Mar-24 4:30 PM View: | Diaz Paul J President and CEO Director | Myriad Genetics Inc. (MYGN) | 24-Mar-24 | Payment of Exercise | 45,822 | $22.24 | $1,019,080.00 | (3%) 1.34M to 1.29M | (16%) |
| 25-Mar-24 4:32 PM View: | Munk Natalie Chief Accounting Officer | Myriad Genetics Inc. (MYGN) | 24-Mar-24 | Payment of Exercise | 981 | $22.24 | $21,817.40 | (2%) 46.37K to 45.38K | (16%) |
| 25-Mar-24 4:30 PM View: | Diaz Paul J President and CEO Director | Myriad Genetics Inc. (MYGN) | 22-Mar-24 | Payment of Exercise | 20,202 | $22.24 | $449,292.00 | (1%) 1.36M to 1.34M | (16%) |
| 25-Mar-24 4:32 PM View: | Munk Natalie Chief Accounting Officer | Myriad Genetics Inc. (MYGN) | 22-Mar-24 | Payment of Exercise | 363 | $22.24 | $8,073.12 | (< 1%) 46.73K to 46.37K | (16%) |
| 25-Mar-24 4:31 PM View: | Haas Kevin Richard Chief Technology Officer | Myriad Genetics Inc. (MYGN) | 22-Mar-24 | Payment of Exercise | 1,685 | $22.24 | $37,474.40 | (1%) 136.67K to 134.99K | (16%) |
| 25-Mar-24 4:31 PM View: | Ancona Margaret SVP, Chief of Staff | Myriad Genetics Inc. (MYGN) | 22-Mar-24 | Payment of Exercise | 730 | $22.24 | $16,235.20 | (< 1%) 91.63K to 90.9K | (16%) |
| 25-Mar-24 4:32 PM View: | Wong Pamela Chief Legal Officer | Myriad Genetics Inc. (MYGN) | 22-Mar-24 | Payment of Exercise | 1,441 | $22.24 | $32,047.80 | (2%) 66.44K to 65.0K | (16%) |
| 25-Mar-24 4:31 PM View: | Muzzey Dale Chief Scientific Officer | Myriad Genetics Inc. (MYGN) | 22-Mar-24 | Payment of Exercise | 1,405 | $22.24 | $31,247.20 | (1%) 113.4K to 112.0K | (16%) |
| 25-Mar-24 4:31 PM View: | Verratti Mark Chief Commercial Officer | Myriad Genetics Inc. (MYGN) | 22-Mar-24 | Payment of Exercise | 1,648 | $22.24 | $36,651.50 | (< 1%) 304.68K to 303.04K | (16%) |
| 18-Mar-24 4:45 PM View: | Haas Kevin Richard Chief Technology Officer | Myriad Genetics Inc. (MYGN) | 15-Mar-24 | Payment of Exercise | 3,306 | $21.16 | $69,955.00 | (2%) 139.98K to 136.67K | |
| 18-Mar-24 4:45 PM View: | Ancona Margaret SVP, Chief of Staff | Myriad Genetics Inc. (MYGN) | 15-Mar-24 | Payment of Exercise | 1,585 | $21.16 | $33,538.60 | (2%) 93.22K to 91.63K | |
| 18-Mar-24 4:46 PM View: | Wong Pamela Chief Legal Officer | Myriad Genetics Inc. (MYGN) | 15-Mar-24 | Payment of Exercise | 2,568 | $21.16 | $54,338.90 | (4%) 69.01K to 66.44K | |
| 18-Mar-24 4:45 PM View: | Muzzey Dale Chief Scientific Officer | Myriad Genetics Inc. (MYGN) | 15-Mar-24 | Payment of Exercise | 3,322 | $21.16 | $70,293.50 | (3%) 116.72K to 113.4K | |
| 18-Mar-24 4:45 PM View: | Verratti Mark Chief Commercial Officer | Myriad Genetics Inc. (MYGN) | 15-Mar-24 | Payment of Exercise | 3,686 | $21.16 | $77,995.80 | (1%) 308.37K to 304.68K | |
| 18-Mar-24 4:44 PM View: | Diaz Paul J President and CEO Director | Myriad Genetics Inc. (MYGN) | 15-Mar-24 | Payment of Exercise | 30,610 | $21.16 | $647,708.00 | (2%) 1.39M to 1.36M | |
| 18-Mar-24 4:45 PM View: | Muzzey Dale Chief Scientific Officer | Myriad Genetics Inc. (MYGN) | 14-Mar-24 | Grant | 49,250 | -- | -- | 73% 67.47K to 116.72K | |
| 18-Mar-24 4:44 PM View: | Leffler Scott J. Chief Financial Officer | Myriad Genetics Inc. (MYGN) | 14-Mar-24 | Grant | 46,095 | -- | -- | 39% 117.77K to 163.87K | |
| 18-Mar-24 4:45 PM View: | Verratti Mark Chief Commercial Officer | Myriad Genetics Inc. (MYGN) | 14-Mar-24 | Grant | 58,631 | -- | -- | 23% 249.74K to 308.37K | |
| 18-Mar-24 4:44 PM View: | Diaz Paul J President and CEO Director | Myriad Genetics Inc. (MYGN) | 14-Mar-24 | Grant | 246,248 | -- | -- | 22% 1.14M to 1.39M | |
| 18-Mar-24 4:45 PM View: | Solaiman Shereen Chief People Officer | Myriad Genetics Inc. (MYGN) | 14-Mar-24 | Grant | 41,042 | -- | -- | 278% 14.75K to 55.79K | |
| 18-Mar-24 4:44 PM View: | Raha Samraat S. Chief Operating Officer | Myriad Genetics Inc. (MYGN) | 14-Mar-24 | Grant | 64,494 | -- | -- | 27% 236.36K to 300.85K | |
| 18-Mar-24 4:45 PM View: | Haas Kevin Richard Chief Technology Officer | Myriad Genetics Inc. (MYGN) | 14-Mar-24 | Grant | 35,178 | -- | -- | 34% 104.8K to 139.98K | |
| 18-Mar-24 4:45 PM View: | Ancona Margaret SVP, Chief of Staff | Myriad Genetics Inc. (MYGN) | 14-Mar-24 | Grant | 35,178 | -- | -- | 61% 58.04K to 93.22K | |
| 18-Mar-24 4:46 PM View: | Munk Natalie Chief Accounting Officer | Myriad Genetics Inc. (MYGN) | 14-Mar-24 | Grant | 7,500 | -- | -- | 19% 39.23K to 46.73K | |
| 04-Mar-24 4:18 PM View: | Solaiman Shereen Chief People Officer | Myriad Genetics Inc. (MYGN) | 01-Mar-24 | Payment of Exercise | 1,108 | $22.18 | $24,575.40 | (7%) 15.86K to 14.75K | (16%) |
| 26-Feb-24 4:09 PM View: | Ancona Margaret SVP, Chief of Staff | Myriad Genetics Inc. (MYGN) | 25-Feb-24 | Payment of Exercise | 2,231 | $22.72 | $50,688.30 | (4%) 60.27K to 58.04K | (13%) |
| 26-Feb-24 4:12 PM View: | Haas Kevin Richard Chief Technology Officer | Myriad Genetics Inc. (MYGN) | 25-Feb-24 | Payment of Exercise | 881 | $22.72 | $20,016.30 | (< 1%) 105.68K to 104.8K | (13%) |
| 29-Jan-24 4:27 PM View: | Leffler Scott J. Chief Financial Officer | Myriad Genetics Inc. (MYGN) | 29-Jan-24 | Grant | 117,770 | -- | -- | 100% 0 to 117.77K | |
| 02-Jan-24 5:52 PM View: | Muzzey Dale Chief Scientific Officer | Myriad Genetics Inc. (MYGN) | 01-Jan-24 | Payment of Exercise | 303 | $19.14 | $5,799.42 | (< 1%) 67.78K to 67.47K | |
| 11-Dec-23 6:41 PM View: | Raha Samraat S. Chief Operating Officer | Myriad Genetics Inc. (MYGN) | 11-Dec-23 | Grant | 236,360 | -- | -- | 100% 0 to 236.36K | |
| 05-Dec-23 4:19 PM View: | Riggsbee Richard Bryan Chief Financial Officer | Myriad Genetics Inc. (MYGN) | 01-Dec-23 | Sale (Planned) | 30,000 | $19.09 | $572,835.00 | (9%) 321.81K to 291.81K | |
| 03-Nov-23 5:12 PM View: | Riggsbee Richard Bryan Chief Financial Officer | Myriad Genetics Inc. (MYGN) | 01-Nov-23 | Sale (Planned) | 30,000 | $15.69 | $470,622.00 | (9%) 351.81K to 321.81K | |
| 19-Oct-23 4:17 PM View: | Wong Pamela Chief Legal Officer | Myriad Genetics Inc. (MYGN) | 18-Oct-23 | Payment of Exercise | 3,309 | $15.06 | $49,833.50 | (5%) 72.32K to 69.01K | |
| 10-Oct-23 4:17 PM View: | Haas Kevin Richard Chief Technology Officer | Myriad Genetics Inc. (MYGN) | 09-Oct-23 | Payment of Exercise | 1,710 | $15.01 | $25,667.10 | (2%) 107.39K to 105.68K | |
| 10-Oct-23 4:15 PM View: | Muzzey Dale Chief Scientific Officer | Myriad Genetics Inc. (MYGN) | 09-Oct-23 | Payment of Exercise | 308 | $15.01 | $4,623.08 | (< 1%) 68.08K to 67.78K | |
| 10-Oct-23 4:22 PM View: | Riggsbee Richard Bryan Chief Financial Officer | Myriad Genetics Inc. (MYGN) | 09-Oct-23 | Payment of Exercise | 12,336 | $15.01 | $185,163.00 | (3%) 364.15K to 351.81K | |
| 10-Oct-23 4:21 PM View: | Verratti Mark Chief Commercial Officer | Myriad Genetics Inc. (MYGN) | 09-Oct-23 | Payment of Exercise | 8,366 | $15.01 | $125,574.00 | (3%) 258.11K to 249.74K | |
| 10-Oct-23 4:19 PM View: | Lambert Nicole Chief Operating Officer | Myriad Genetics Inc. (MYGN) | 09-Oct-23 | Payment of Exercise | 12,111 | $15.01 | $181,786.00 | (5%) 236.1K to 223.99K | |
| 27-Sep-23 4:18 PM View: | Muzzey Dale Chief Scientific Officer | Myriad Genetics Inc. (MYGN) | 26-Sep-23 | Payment of Exercise | 133 | $15.99 | $2,126.67 | (< 1%) 68.22K to 68.08K | |
| 27-Sep-23 4:32 PM View: | Riggsbee Richard Bryan Chief Financial Officer | Myriad Genetics Inc. (MYGN) | 26-Sep-23 | Payment of Exercise | 4,517 | $15.99 | $72,226.80 | (1%) 368.67K to 364.15K | |
| 27-Sep-23 4:30 PM View: | Verratti Mark Chief Commercial Officer | Myriad Genetics Inc. (MYGN) | 26-Sep-23 | Payment of Exercise | 3,523 | $15.99 | $56,332.80 | (1%) 261.63K to 258.11K | |
| 27-Sep-23 4:27 PM View: | Lambert Nicole Chief Operating Officer | Myriad Genetics Inc. (MYGN) | 26-Sep-23 | Payment of Exercise | 4,402 | $15.99 | $70,388.00 | (2%) 240.51K to 236.1K | |
| 27-Sep-23 4:21 PM View: | Haas Kevin Richard Chief Technology Officer | Myriad Genetics Inc. (MYGN) | 26-Sep-23 | Payment of Exercise | 858 | $15.99 | $13,719.40 | (< 1%) 108.25K to 107.39K |
